MediFind found 58 doctor with experience in Mast Cell Activation Syndrome (MCAS) near Boston, MA. Of these, 46 are Experienced, 7 are Advanced, 3 are Elite and 2 are Distinguished.
Dana-Farber Cancer Institute, Inc.
Daniel Deangelo is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Deangelo is rated as an Elite provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Deangelo is currently accepting new patients.
Hale Building For Transformative Medicine On BWH Main Campus
Matthew Giannetti is an Internal Medicine provider in Boston, Massachusetts. Dr. Giannetti is rated as an Elite provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Hereditary Alpha-Tryptasemia, and Anaphylaxis.
Brigham & Women's Hospital
Matthew Hamilton is a Gastroenterologist in Chestnut Hill, Massachusetts. Dr. Hamilton is rated as an Elite provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Mast Cell Activation Syndrome (MCAS), Ulcerative Colitis, Crohn's Disease, Endoscopy, and Knee Replacement.
Brenton Mar is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Mar is rated as a Distinguished provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Mast Cell Activation Syndrome (MCAS), Aase Syndrome, Leukemia, and Transient Erythroblastopenia of Childhood.
Brigham And Womens Physicians Organization Inc
Dr. Mullally is the Associate Chief of Clinical Neurology at the Brigham and Women’s Faulkner Hospital. He completed his internal medicine residency at Rutgers Affiliated Hospitals and his neurology residency at the University of Miami and the Harvard Longwood Neurology Training Program at Brigham and Women’s Hospital. Dr. Mullally was a chief medical resident at Rutgers and chief resident in neurology at Harvard. After completing his neurology residency in 1982, Dr. Mullally opened a comprehensive headache clinic in New Jersey. In 1989, he began working at Harvard Community Health Plan (now Harvard Vanguard Medical Associates) and started the headache program which he directed until he moved to work full time at Brigham and Women’s Faulkner Hospital and Brigham and Women’s Hospital in May of 2013. Dr. Mullally is also Director of Sports Neurology at the MGH/BWH Foxborough facility, and sees general neurology patients at Brigham and Women’s Faulkner Hospital. He has been a member of the American Headache Society since 1982, and is board certified in internal medicine, neurology and headache medicine. Dr. Mullally is rated as an Experienced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Migraine, Headache, Migraine with Brainstem Aura, and Familial Dysautonomia.
Dana-Farber Cancer Institute, Adult Leukemia Program
Richard Stone is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Stone is rated as an Experienced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
Dana-Farber Cancer Institute, Adult Leukemia Program
Martha Wadleigh is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Wadleigh is rated as an Experienced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). Her top areas of expertise are Myelofibrosis, Acute Myeloid Leukemia (AML), Myeloproliferative Neoplasms (MPN), Bone Marrow Aspiration, and Bone Marrow Transplant.
Brigham And Women's Hospital, Heart And Vascular Center
Dr. David M. Systrom is a physician at Brigham and Women’s Hospital. He is also an assistant professor of medicine at Harvard Medical School.He received his medical degree from Dartmouth Medical School (now known as Geisel School of Medicine). He then completed a residency in internal medicine at Emory University Hospital, followed by a fellowship in internal medicine at Massachusetts General Hospital. He is board certified in internal medicine and pulmonary disease.An active investigator and director of the Massachusetts General Hospital Cardiopulmonary laboratory, Dr. Systrom regularly publishes research examining pulmonary hypertension, pulmonary vascular disease, right heart failure and thromboembolic disease. He has authored over 130 peer-reviewed publications, has received funding from the National Institutes of Health and the American Heart Association, and has been named to the annual list of the Best Doctors in America. Dr. Systrom is a member of the American Thoracic Society, the American Heart Association and the American Physiological Society. He has special expertise in the pathophysiology of exercise intolerance in ME/CFS and Long Covid and is conducting clinical trials investigating the same. Dr. Systrom is rated as an Experienced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Hyperventilation, and Heart Failure with Preserved Ejection Fraction (HFpEF).
Beth Israel Deaconess Medical Center
Trisha Ray is an Allergy and Immunologist in Boston, Massachusetts. Dr. Ray is rated as an Experienced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). Her top areas of expertise are Hives, Angioedema, Grass Allergy, and Allergic Rhinitis.
Boston Food Allergy Center LLC BI Network
John Leung is an Allergy and Immunologist in Boston, Massachusetts. Dr. Leung is rated as an Advanced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Eosinophilic Esophagitis, Eosinophilic Enteropathy, Eosinophilic Colitis, Tissue Biopsy, and Endoscopy.
Tufts Medical Center Dermatology
Joshua Mervis is a Dermatologist in Boston, Massachusetts. Dr. Mervis is rated as an Experienced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Melanoma, Comedones, Liver Spots, and Universal Acquired Melanosis.
BIDMC - Division Of Gastroenterology/GI East
Jacqueline Wolf is an Internal Medicine provider in Boston, Massachusetts. Dr. Wolf is rated as an Experienced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). Her top areas of expertise are Crohn's Disease, Irritable Bowel Syndrome (IBS), Sclerosing Mesenteritis, Colonoscopy, and Endoscopy.
Brigham And Women's Primary Care Associates Of Longwood
Dr. Larissa Nekhlyudov is a board-certified general internist and Medical Director of Primary Care Associates, Longwood. Dr. Nekhlyudov received her medical degree from the Mount Sinai School of Medicine, and completed residency training at the Yale Primary Care Program. Prior to coming to the BWH, she practiced internal medicine at Harvard Vanguard Medical Associates for over 15 years. In addition to being a primary care provider, she has extensive experience in cancer-related research and education. She is particularly interested in improving the care of cancer survivors and the interplay between primary and oncology care. Dr. Nekhlyudov is rated as an Advanced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). Her top areas of expertise are Mast Cell Activation Syndrome (MCAS), Breast Cancer, Anal Cancer, and Severe Acute Respiratory Syndrome (SARS).
Brigham And Womens Physicians Organization Inc
Matthew Vitale is an Internal Medicine provider in Boston, Massachusetts. Dr. Vitale is rated as an Experienced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Mast Cell Activation Syndrome (MCAS), Liver Failure, Endoscopy, and Colonoscopy.
Brigham And Womens Physicians Organization Inc
Erin O'fallon is an Internal Medicine provider in Boston, Massachusetts. Dr. O'fallon is rated as an Experienced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). Her top areas of expertise are Pneumonia, Necrosis, Mast Cell Activation Syndrome (MCAS), Endoscopy, and Gastrostomy.
Brigham And Women's Hospital
Yan Epelboym is an Interventional Radiologist in Boston, Massachusetts. Dr. Epelboym is rated as an Experienced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Osteoarthritis, Arthritis, SVC Obstruction, Gallbladder Disease, and Liver Embolization.
Brigham And Women's Faulkner Hospital, Department Of Neurology
Peter Novak is a Neurologist in Jamaica Plain, Massachusetts. Dr. Novak is rated as an Advanced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Familial Dysautonomia, Vasoconstriction, Hereditary Sensory Neuropathy Type 1 (HSN1), Peripheral Neuropathy, and Deep Brain Stimulation.
Anthony Boral is an Oncologist in Cambridge, Massachusetts. Dr. Boral is rated as an Advanced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). His top areas of expertise are Mast Cell Activation Syndrome (MCAS), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Gastrointestinal Stromal Tumor.
Ilene Galinsky is a Hematologist Oncology provider in Boston, Massachusetts. Dr. Galinsky is rated as an Advanced provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). Her top areas of expertise are Acute Myeloid Leukemia (AML), Systemic Mastocytosis, Leukemia, and Mast Cell Activation Syndrome (MCAS).
Office
Maria Castells is an Allergy and Immunologist in Chestnut Hill, Massachusetts. Dr. Castells is rated as a Distinguished provider by MediFind in the treatment of Mast Cell Activation Syndrome (MCAS). Her top areas of expertise are Mast Cell Activation Syndrome (MCAS), Systemic Mastocytosis, Anaphylaxis, and Exercise-Induced Anaphylaxis (EIA).
Last Updated: 02/22/2026








